Lilly Endowment Inc.,作为Eli Lilly & Co的董事,在2025年2月21日减持了合计90,945股普通股票。此次减持可能反映出对公司股价在当下水平的重新评估。大笔股票售出可能对股市产生不利影响,因此,投资者需对公司未来业绩持谨慎态度并保持关注。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.